Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Nicolas L, Gilbert"'
Publikováno v:
BMC Public Health, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background In 2019, the World Health Organization (WHO) designated vaccine hesitancy as one of the ten leading threats to global health. Vaccine hesitancy exists when vaccination services are available and accessible, but vaccine uptake is l
Externí odkaz:
https://doaj.org/article/352df59408e64d1fb6e5878dbd39f1cd
Autor:
Mireille Guay, Aubrey Maquiling, Ruoke Chen, Valérie Lavergne, Donalyne-Joy Baysac, Audrey Racine, Eve Dubé, Shannon E. MacDonald, Nicolas L. Gilbert
Publikováno v:
BMC Public Health, Vol 22, Iss 1, Pp 1-16 (2022)
Abstract Background By July 2021, Canada had received enough COVID-19 vaccines to fully vaccinate every eligible Canadian. However, despite the availability of vaccines, some eligible individuals remain unvaccinated. Differences in vaccination uptake
Externí odkaz:
https://doaj.org/article/99bbd9c091f14378bb83e687d34a7970
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 4, Pp 868-874 (2018)
Delaying vaccination increases the period of vulnerability of children against vaccine-preventable diseases. We used a nationally representative sample of Canadian two-year-old children to explore factors associated with delays in the uptake of the f
Externí odkaz:
https://doaj.org/article/7498f434483e40e6a749022b14434cdf
Autor:
Sarah E. Wilson, Susan Quach, Shannon E. MacDonald, Monika Naus, Shelley L. Deeks, Natasha S. Crowcroft, Salaheddin M. Mahmud, Dat Tran, Jeff Kwong, Karen Tu, Nicolas L. Gilbert, Caitlin Johnson, Shalini Desai
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 8, Pp 1928-1936 (2017)
Accurate and complete immunization data are necessary to assess vaccine coverage, safety and effectiveness. Across Canada, different methods and data sources are used to assess vaccine coverage, but these have not been systematically described. Our p
Externí odkaz:
https://doaj.org/article/d877b3d322fb4f428d7e22ae628bdf3e
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 6, Pp 1447-1453 (2017)
Vaccination coverage remains suboptimal in Canada and sporadic outbreaks of vaccine-preventable diseases such as measles and pertussis continue to occur. This study was undertaken to identify sociodemographic determinants of total non-vaccination (ha
Externí odkaz:
https://doaj.org/article/60b487fbdc6940d2880cf1389e3a6973
Autor:
Theresa W Gyorkos, Antonio Montresor, Vicente Belizario, Beverley-Ann Biggs, Mark Bradley, Simon J Brooker, Martin Casapia, Philip Cooper, Sila Deb, Nicolas L Gilbert, Rubina Imtiaz, Virak Khieu, Stefanie Knopp, Ornella Lincetto, Layla S Mofid, Denise Mupfasoni, Cori Vail, Jozef Vercruysse
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 12, Iss 11, p e0006740 (2018)
Externí odkaz:
https://doaj.org/article/f1daea604a434619b8406298b264e5b6
Autor:
Mireille, Guay, Aubrey, Maquiling, Ruoke, Chen, Valérie, Lavergne, Donalyne-Joy, Baysac, Jackie, Kokaua, Catherine, Dufour, Eve, Dubé, Shannon E, MacDonald, Nicolas L, Gilbert
This study's objective was to examine sociodemographic disparities in COVID-19 vaccine uptake and vaccination intent in the Canadian provinces by identifying factors associated with vaccine uptake in seniors prioritized for vaccination at the time of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e485fced70bdd86f0baaa1337fad400
Publikováno v:
Preventive Medicine. 123:278-287
Childhood vaccination efforts in Canada have been negatively impacted by parents' vaccine hesitancy based on their knowledge, attitudes, and beliefs (KAB) about vaccinations. Less understood is the extent to which child vaccination receipt and KAB va
Autor:
Theresa W Gyorkos, Nicolas L Gilbert
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 8, Iss 7, p e2912 (2014)
Externí odkaz:
https://doaj.org/article/4d559982915c4a25bb6b7b675cee367e
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 6, Iss 9, p e1783 (2012)
The intensity categories, or thresholds, currently used for Trichuris trichiura (ie. epg intensities of 1-999 (light); 1,000-9,999 epg (moderate), and ≥ 10,000 epg (heavy)) were developed in the 1980s, when there were little epidemiological data av
Externí odkaz:
https://doaj.org/article/25993440a5eb491f88c6da7394eff55c